Pathology & Laboratory Medicine

You are here


Weill Cornell Medicine Awarded $9 Million Prestigious Grant for Mantle Cell Lymphoma Research

Selina Chen-Kiang

Selina Chen-Kiang, PhD
Professor of Pathology and Laboratory Medicine

Weill Cornell Medicine has been awarded a five-year, $9 million Program Project Grant (P01) from the National Cancer Institute (NCI) to better understand how and why patients with an aggressive and incurable form of lymphoma initially respond to treatment, only to relapse over time. The findings may enable investigators to develop superior therapies that are effective, well tolerated and tailored to individual patients with mantle cell lymphoma.

The NCI, part of the National Institutes of Health, offers Program Project Grants to support integrated, multi-project research involving a number of independent investigators who together can improve scientific understanding on a common theme or disease area. This is the first P01 that is solely focused on MCL, which will seek to capitalize on the institution’s strengths in basic and translational research for blood malignancies.

Dr. Massimo Loda Appointed Chair of the Department of Pathology and Laboratory Medicine

Dr. Massimo Loda, an internationally renowned molecular pathologist, has been appointed chair of the Department of Pathology and Laboratory Medicine at Weill Cornell Medicine and pathologist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective Feb. 1.

Dr. Loda will helm the institutions’ pathology enterprise, which offers cutting-edge clinical and laboratory services and engages in high-impact science, with a strong focus on the biology of blood and solid tumor malignancies, including prostate cancer. In his new role and as a member of Weill Cornell Medicine’s Sandra and Edward Meyer Cancer Center, Dr. Loda will enhance the Department of Pathology and Laboratory Medicine’s diagnostic capabilities by introducing new techniques, including those that leverage computational pathology and large datasets to identify patterns and trends in disease. He will also seek to recruit outstanding new physicians and scientists to expand the department’s research portfolio and provide exemplary training to the next generation of pathologists. Dr. Loda will succeed Dr. Daniel Knowles, who has served as chair of the department for nearly 25 years.

Giorgio Inghirami, MD appointment to Vice Chair for Hematopathology

Giorgio Inghirami, M.D.
Vice Chair for Hematopathology &
Director of Immunopathology Laboratory

The Department is pleased to announce the appointment of Giorgio Inghirami, MD as Vice Chair for Hematopathology.

As many of you know, Dr. Inghirami joined our Department in September 2013, as Director of the Immunopathology Laboratory. He is a distinguished scientist and accomplished academic hematopathologist, internationally recognized as an expert in the morphologic, flow cytometric and molecular diagnosis and characterization of malignant lymphomas, both for clinical diagnosis and research. Dr. Inghirami will continue to serve as Director of the Immunopathology Laboratory.

Giorgio succeeds Dr. Attilio Orazi, who is joining the Paul L. Foster School of Medicine at the Texas Tech University Health Sciences Center in El Paso, Texas, as Chair of Pathology.

Please join us in congratulating Dr. Giorgio Inghirami.

Weill Cornell Medicine Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464 Fax: (212) 746-8192